BATS:CPRX   Catalyst Pharmaceuticals, Inc.
It is time to buy the shares. On 28 February they will report the fourth quarter. I expect very good news, but this is irrelevant. You can see that there is a turning point in the chart. The first target is around 15.20, then it is going to refill the gap.
And of course in the long term, this short is very bullish.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.